Skip to main content
Premium Trial:

Request an Annual Quote

Mirus Bio Wins $900K SBIR Grant to Develop miRNA Tech With Potential Dx Apps

NEW YORK (GenomeWeb News) — Mirus Bio has received a two-year, $900,000 Phase II Small Business Innovative Research grant to develop its microRNA-labeling technology for clinical research and “potential diagnostic applications,” the company said today.
The Madison, Wis.-based miRNA and siRNA transfection company said it will use the money to develop products that will study the link between miRNAs and undisclosed diseases that it will eventually “enable diagnostic testing for miRNAs as biomarkers for disease.”
Mirus said it will market products resulting from the research. The company currently sells a Label IT miRNA kit that is used in microarray analysis.
Mirus will conduct the work in collaboration with Gregory Tsongalis, director of molecular pathology at the Dartmouth Hitchcock Medical Center in Lebanon, NH, it said.
The grant came from the National Institute of General Medical Sciences.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.